Miele et al. indicated that NAFLD patients have a reduced expression of ZO-1 (zona occludens 1), a major tight junction protein, which results in higher intestinal permeability [31]. This evidence concerns the gene TJP1 and metabolic dysfunction-associated steatotic liver disease.